DC3 Therapeutics Competitors

Bio-synthesis is a biology contract manufacturer of high quality nucleic acids, peptides and other molecular biology products for the research, diagnostic and therapeutic industries. Bio-Synthesis operates an ISO 9001 certified facility and is compliant with 21 CFR 210/211 and 21 CFR 820. Our solutions help advance drug discovery and bio-medical research. Founded in 1984, Bio-Synthesis is a privately held firm based in Lewisville, Texas. Custom Peptide Specialists Bio-Synthesis has been a provider of Peptide Synthesis services to the life science research community since 1984. We offer a complete range of premium quality peptide products ranging from bulk API polypeptides to high throughput library peptides and peptide array preparation. We also provide a large number of peptide modifications as well as peptide synthesis for diagnostic and therapeutic applications. Bio-Synthesis specializes in both, liquid phase and solid phase fmoc peptide synthesis chemistry. We have a long standing record in preparing biologically active polypeptides including long, complex and hydrophobic peptides synthesized to your specifications. Custom Oligonucleotide Specialists As a pioneer in oligonucleotide synthesis, Bio-Synthesis has been pursuing the development of new oligonucleotide-based techniques that can produce compounds with superior binding affinity and chemical/biological stability. As such, Bio-Synthesis has introduced a third generation of nucleic acid analogs, Bridged Nucleic Acid (BNA). These are RNA analogues which can be synthesized and spiked with DNA or RNA in order to modify the formation of nucleic acid helices.

Proteos is committed to providing a quality foundation for drug discovery. We are a contract research organization that provides the highest quality recombinant protein expression and purification services for drug discovery research in the biotechnology and pharmaceutical industries. Our highly-skilled team of scientists utilizes diverse experience and optimized methods within a customized workflow that focuses on the end product from square one. Fully customized experimental designs allow flexibility and adaptation during the project, thus enabling data-driven decisions that lead to a higher probability of project success. Proteos is passionate about drug discovery. We know that reliable reagents are critical for the ultimate success of drug discovery programs. Proteos is a wholly owned subsidiary of NIS, enabling a streamlined gene-to-structure workflow.

EXONBIO is a recombinant antibody and recombinant protein company. SPIN (Single Plasma Cell Interrogation) Technology for rabbit recombinant monoclonal antibody (rrMAb) development.